price

NASDAQ · CTMX
CytomX Therapeutics, Inc.
Healthcare · Biotechnology
$2.23
Down-$0.10 (-4.09%)
Updated Oct 27, 2026, 6:04 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 686.8M
- P/E ratio
- 23.88
- Dividend yield
- 0.00%
- 52-week range
- $2.20 – $8.21
- Volume
- 5.22M
- Avg. volume
- 3.54M
Price performance · CTMX
CTMX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 26, 2026
CTMX closed at $2.23 after 21 trading sessions, down 17.29% for the selected period.
- Last close
- $2.23
- Period change
- -17.29%
- Period low
- $2.23
- Period high
- $2.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | $2.31 | $2.33 | $2.18 | $2.225 | 5.22M |
| Oct 23, 2026 | $2.41 | $2.42 | $2.305 | $2.32 | 4.37M |
| Oct 22, 2026 | $2.38 | $2.47 | $2.37 | $2.44 | 2.44M |
| Oct 21, 2026 | $2.525 | $2.61 | $2.39 | $2.40 | 3.11M |
| Oct 20, 2026 | $2.36 | $2.55 | $2.34 | $2.51 | 4.1M |
| Oct 19, 2026 | $2.31 | $2.35 | $2.24 | $2.34 | 2.05M |
| Oct 16, 2026 | $2.40 | $2.45 | $2.26 | $2.28 | 3.18M |
| Oct 15, 2026 | $2.26 | $2.435 | $2.25 | $2.41 | 2.99M |
| Oct 14, 2026 | $2.30 | $2.345 | $2.20 | $2.23 | 3.35M |
| Oct 13, 2026 | $2.45 | $2.45 | $2.32 | $2.325 | 5.22M |
| Oct 12, 2026 | $2.56 | $2.575 | $2.41 | $2.42 | 4M |
| Oct 9, 2026 | $2.46 | $2.58 | $2.44 | $2.57 | 3.04M |
| Oct 8, 2026 | $2.51 | $2.545 | $2.43 | $2.47 | 4.5M |
| Oct 7, 2026 | $2.53 | $2.65 | $2.52 | $2.55 | 2.34M |
| Oct 6, 2026 | $2.61 | $2.63 | $2.505 | $2.56 | 1.96M |
| Oct 5, 2026 | $2.55 | $2.67 | $2.48 | $2.58 | 1.77M |
| Oct 2, 2026 | $2.68 | $2.68 | $2.55 | $2.56 | 2.62M |
| Oct 1, 2026 | $2.71 | $2.775 | $2.62 | $2.63 | 2.7M |
| Sep 30, 2026 | $2.78 | $2.80 | $2.70 | $2.72 | 3.22M |
| Sep 29, 2026 | $2.70 | $2.825 | $2.65 | $2.75 | 4.46M |
| Sep 28, 2026 | $2.68 | $2.76 | $2.60 | $2.69 | 2.69M |
Latest CTMX news
The latest Smart Investors Daily articles mentioning CTMX.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

